PGHH declares interim dividend of ₹195/share, including ₹25 special dividend.
Procter & Gamble Hygiene and Health Care Limited declared an interim dividend of ₹195 per equity share for FY25-26, including a ₹25 special dividend. The dividend will be paid by February 27, 2026. The record date is February 5, 2026. The company also approved its unaudited financial results for the quarter ended December 31, 2025.
The dividend payout is a significant financial event for shareholders, impacting their returns. The quantum of the dividend and the inclusion of a special dividend suggest a positive financial performance or outlook, warranting a medium impact.
The declaration of an interim dividend, especially with a special component, is generally viewed positively by investors as it directly returns value to shareholders.
Procter & Gamble Hygiene and Health Care Limited (PGHH) announced its unaudited financial results for the quarter ended December 31, 2025. The Board of Directors, in their meeting held on January 30, 2026, approved these results.
Additionally, the Board declared an interim dividend of ₹195 per equity share for the Financial Year 2025-26. This includes a one-time special dividend of ₹25 per equity share. The dividend is scheduled to be paid on or before February 27, 2026. The record date for determining the eligibility for this dividend payment has been fixed as February 5, 2026.
The company also reported its financial performance for the quarter. While specific profit figures are not detailed in the provided text for the summary, the financial results statement indicates revenue from operations and other income contributing to the total income for the period.
What to do with a filing like this
Procter & Gamble Hygiene and Health Care Limited filed this with the NSE as a statutory disclosure, categorised under dividend. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Procter & Gamble Hygiene and Health Care Limited. Read the original for the full detail.